Table 1 Patient demographics and clinical characteristics
Characteristic | Treatment-naïve patients (n = 17) | Treatment-experienced patients (n = 13) | All patients, (n = 30) |
|---|---|---|---|
Sex, n (%) | |||
 Male  Female | 4 (23.5) 13 (76.5) | 4 (30.8) 9 (69.2) | 8 (26.7) 22 (73.3) |
Age, n (%) | |||
  ≥ 60 years-old   < 60 years-old | 7 (41.2) 10 (58.8) | 7 (53.8) 6 (46.2) | 14 (46.7) 16 (53.3) |
Genotypea, n (%) | |||
 1b  2a | 9 (52.3) 8 (47.7) | 12 (92.3) 1 (7.7) | 21 (70.0) 9 (30.0) |
HCV RNA, n (%) | |||
  ≥ 1.0 × 106 IU/mL   < 1.0 × 106 IU/mL | 7 (41.2) 10 (58.8) | 9 (69.2) 4 (30.8) | 16 (53.3) 14 (46.7) |
Child-Pugh scorea, n (%) | |||
  ≥ 7   < 7 | 7 (41.2) 10 (58.8) | 2 (15.4) 11 (84.6) | 9 (30.0) 21 (70.0) |
Splenectomy, n (%) | |||
 Yes  No | 6 (35.3) 11 (64.7) | 3 (23.1) 10 (76.9) | 9 (30.0) 21 (70.0) |